After adjusting for gender, age, baseline FT3, baseline FT4, baseline sTSH, and baseline TRAb, compared with MMI alone, treatment with XKC+MMI showed a trend towards an association with a decrease in TRAb levels at 3 months (univariate: β=-2.888, 95% CI: -5.45–0.326, P=0.029; multivariate: β=-2.405, 95% CI: -4.794–0.016, P=0.051) ( Table 5 ). 4.
Ventricle volume at M0 showed a trend for predicting FMSC change (std. β = –0.30, uncorrected p = 0.029), but did not survive correction for multiple comparisons.
The age group 77–105 showed a trend toward higher risk in the age group subgroup analysis (HR = 3.67, 95% CI: 1.14 to 11.78, P -value = 0.029).
Moreover, all frequency ranges showed a trend towards higher average retrosplenial-connectivity during the initial stage of the session, but was only significant for theta (Fig. 5 Aiii; =1.89, p = 0.0295) and beta (Fig. 5 Biii; =1.89, p =0.0295) frequency ranges, and not for the gamma range (Fig. 5 Ciii; =1.62, p = 0.0528).
minuta showed a trend for positive correlation with the distance traveled of male mice ( R 2 = 0.042, P = 0.03, Fig. 2D ) but not of females ( R 2 = 4.6e −4 , P = 0.84, Fig. 2D ).
6.1%, p = 0.382) and showed a trend toward increased biological complications (58.4% vs. 51.1%, p = 0.03) compared to non-diabetics.
Similarly, the association between WMH and global cognition as well as attention remained, while the associations between WMH and executive function or language showed a trend toward significance when adding Aβ-SUVR as a covariate in addition to adjustment for type-2 diabetes-related characteristics and ICV (β = − 0.02, SD = 0.01, p = 0.03 for global cognition, β = − 0.03, SD = 0.01, p = 0.03 for attention, β = − 0.02, SD = 0.01, p = 0.06 for executive functions, and β = − 0.02, SD = 0.01, p = 0.06 for language, Table 4 B).
In addition, the HSCT subgroup showed a trend toward improved OS compared with the non-HSCT subgroup, with 2-year OS rates of 92.3% and 53.9%, respectively ( p = 0.03) (Fig. 1E, F ).
Analysis of specific sexual dysfunction symptoms showed that patients reporting problems with genital tract lubrication during intercourse showed a trend toward declaring the necessity of using a sex toy to achieve orgasm (unadjusted P = 0.03; non-significant after FDR).
Muscle wet‐weight ratios showed a trend of improvement, with a significant increase in quadriceps wet weight in the PV‐cre group (Unpaired t ‐test, t 6 = 2.818, p = 0.030; Figure 4a–d ).
Those taking short-acting opioids as needed (PRN) showed a trend toward reduced opioid dose across the daily assessments (β=–29.88, SE 10.68, P =.03), although this association did not survive correction.
After FDR correction, the association between the old age group and higher SID scores showed a trend toward significance (β = 0.0183, 95 % CI [0.0022, 0.0344], q = 0.074; original p = 0.030) ( Fig. 2 a).
Other lymphoid subpopulations showed a trend for physiological regeneratior, with a statistically significant increase in CD8+/CD45RO+ memory T-cell counts (76.2 ± 94.1 vs. 144.4 ± 127.0 cells/μL, p = 0.03). 3.5.
Between-group comparisons showed a trend toward a greater IOP decrease on POD 1 (p=0.03), but not POM 3 (p=0.81).
In our study, weight loss (52.8%) and cough (59.0%) were the two most common presenting complaints that showed a trend towards a decreased survival (p = 0.03) in patients with ESSCLC.
In the under-5 age group, the SMA 3a group also showed a trend towards increasing score at and after 12 months, although this was only significant at 6 months in both the RHS and HFMSE (median 6 ( p = 0.03) and 3 ( p = 0.06), respectively).
In addition, patients with ESR1m showed a trend of OS improvement in Elacestrant (HR = 0.59; p = 0.03).
Among treatment categories, steroid use showed a trend in the univariate analysis and became independently associated with lung cancer after adjustment (OR 3.06, 95% CI 1.18–8.73, p = 0.03).
An analysis comparing PFS by first-line therapy choice across KRAS variants showed a trend toward improved PFS with first-line fluorouracil-based therapy versus gemcitabine-based therapy for G12R (12.17 v 9.9 months; HR, 1.73 [95% CI, 1.05 to 2.84]; P = .0305) and the opposite trend with reduced PFS with first-line fluorouracil-based therapy for Q61 (3.13 v 5.6 months; HR, 0.46 [95% CI, 0.21 to 0.99]; P = .0479; Data Supplement, Table S2).
Adjusted linear regression showed a trend for an association between longer DD and a greater sNfL z -score ( B = 0.35; p = 0.031; adjusted p [5] = 0.16); however, Spearman’s correlation was not significant (rho = 0.18; p = 0.078; n = 98) ( Figures 2 – 4 ).
Infants of SCZ mothers showed a trend towards less attentiveness ( p = 0.032) compared to the infants of MDD mothers.
In addition, the SDNN values showed a trend of a decrease followed by an increase in the pre- and post-tests, and the differences in the changes were significant ( F = 13.078, p = 0.032, ɳp 2 = 0.231).
13.5% in Q1, p < 0.001), and alcohol consumption patterns showed a trend towards higher consumption in the lower LDL/HDL ratio groups ( p = 0.032).
However, participants with GG genotypes showed a trend toward better performance in the visuospatial function compared with the AA + AG genotypes ( p = 0.032).
However, the Mann–Whitney U test comparing the biceps brachii group and the brachialis plus brachioradialis group on pronator teres toxin dose showed a trend towards significance ( p = 0.033, adjusted alpha = 0.0167), suggesting that patients in the biceps brachii group tended to receive a higher dose of pronator teres toxin.